←Back to Expert Scholars
Translational Medicine / 转化医学Primary CNS Lymphoma, Neuro-Oncology
Christian Grommes
MD
🏢Memorial Sloan Kettering Cancer Center🌐USA
Associate Attending Neurologist
50
h-index
0
Key Papers
0
Key Contributions
👥Biography 个人简介
Christian Grommes leads the PCNSL program at Memorial Sloan Kettering and pioneered ibrutinib for CNS lymphoma after identifying BTK pathway dependence. He has conducted key trials of BTK inhibitors and combination regimens in relapsed PCNSL. His work has expanded therapeutic options for refractory disease.
Share:
🧪Research Fields 研究领域
primary CNS lymphoma
ibrutinib
BTK inhibitors CNS
relapsed PCNSL
secondary CNS lymphoma
🎓Key Contributions 主要贡献
Representative Works 代表性著作
📄Data Sources 数据来源
Last updated: 2026-04-01 | All information from publicly available academic sources
Related Experts 相关专家
Antoni Ribas
UCLA Jonsson Comprehensive Cancer Center
Melanoma ImmunotherapyCheckpoint Inhibitors
Drew M. Pardoll
Johns Hopkins University
Cancer ImmunologyPD-1/PD-L1 Pathway
Padmanee Sharma
MD Anderson Cancer Center
Bladder Cancer ImmunotherapyImmune Profiling
Naiyer A. Rizvi
Columbia University Irving Medical Center
Lung Cancer ImmunotherapyTumor Mutational Burden
关注 Christian Grommes 的研究动态
Follow Christian Grommes's research updates
留下邮箱，当我们发布与 Christian Grommes（Memorial Sloan Kettering Cancer Center）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment